Diese Website verwendet Cookies, um das Angebot nutzerfreundlicher und effektiver zu machen. Mit der Nutzung dieser Website stimmen Sie der Verwendung von Cookies zu.Weitere Informationen über die Verwendung von Cookies und die Möglichkeit der Verwendung von Cookies zu widersprechen, finden Sie hier.
The third-generation Connected Health Platform (CHP) from Phillips-Medisize, a Molex company, helps pharmaceutical companies and drug delivery device developers reduce risk, cost and time to market with leading innovation and technology accelerators. This cloud-based platform provides a safe, scalable and trusted medical device data system (MDDS) built on technology from the world leader in health data interoperability. It encompasses extensive information-sharing, analytics capabilities, robust cybersecurity and streamlined regulatory documentation. Its advanced analytics package is designed for connected drug delivery devices, biosensors and regulated Mobile Medical Applications (SaMD/MMA). Ultimately, connected health solutions may help patients improve medication adherence and manage chronic conditions.
Phillips-Medisize, a Molex company is a global-leader in outsource device strategy, design, development & technologydriven manufacturing. Customised medical devices include disposables, insulin pens, glucose meters, inhalers, single-use surgical devices, consumable diagnostic components, tube sets, catheters, diagnostic arrays, and much more. Expertise in drug delivery devices with particular focus on personal connected health solutions.
Molex offers medical device OEMs a trusted source to build competitive advantages in electronic systems and devices.With our portfolio of medical interconnect solutions and a deeply consultative approach we provide end-to-end solutions that enable success.